LEADER 01209nam0 22003133i 450 
001 SUN0130355
005 20200729114446.299
010   $d0.00
017 70$2N$a978-3-319-75836-7
100   $a20200729d2018       |0engc50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $a*Targeting the DNA Damage Response for Anti-Cancer Therapy$fJohn Pollard, Nicola Curtin editors
205   $aCham : Springer, 2018
210   $aix$d401 p. ; 24 cm
215   $aPubblicazione in formato elettronico
410  1$1001SUN0111323$12001 $a*Cancer Drug Discovery and Development$1210  $aNew York$cSpringer.
620   $aCH$dCham$3SUNL001889
702  1$aPollard$b, John$3SUNV103857
702  1$aCurtin$b, Nicola$3SUNV103858
712   $aSpringer$3SUNV000178$4650
712   $aHumana$3SUNV000600$4650
801   $aIT$bSOL$c20200921$gRICA
856 4 $uhttps://link.springer.com/book/10.1007%2F978-3-319-75836-7
912   $aSUN0130355
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 6741                      $e15EB 6741              20200729            
996   $aTargeting the DNA Damage Response for Anti-Cancer Therapy$91754035
997   $aUNICAMPANIA